Molecular Docking Studies of substituted 3-methyl-4-oxo-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives

M. R., Holam and M., Komala (2023) Molecular Docking Studies of substituted 3-methyl-4-oxo-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives. Research Journal of Pharmacy and Technology. pp. 4825-4830. ISSN 0974-3618

[thumbnail of Molecular Docking Studies of substituted 3-methyl-4-oxo-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.pdf] Archive
Molecular Docking Studies of substituted 3-methyl-4-oxo-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.pdf

Download (565kB)

Abstract

Molecular Docking Studies of substituted 3-methyl-4-oxo-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives Holam M. R. Ph.D. Research Scholar, VEL’s Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamilnadu, 600117, India. Komala M. Department of Pharmaceutics, School of Pharmaceutical Sciences, VELS Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamilnadu, 600117, India.

A molecular docking study is advance technique of structure based drug discovery and help to develop more heterocyle with promising pharmacological activity. In the present study molecular docking analysis was carried out for the various pyrimidine fused heterocycle derivatives (6a-y and 7a-r)which are planned, using the C-Docker protocol. Roscovitine-complexed X-ray crystallographic enzyme (CDK2) substrate.The result of molecular docking studies showed that 6r, 6l and 6p compounds showed higher docking scores compared to those in the series. Compound 6rexhibited one H-bonding interaction between the nitrogen of Cyanide group of pyrimidine at 5th position with LYS89 (1.80 Å) and four Pi-Alkyl bond with LEU134, ILE10, VAL18 and ALA144 (4.47, 4.46, 5.29, 5.04 Å respectively) one carbon-hydrogen bond with LEU83 (2.73 Å), one Pi-Donor Hydrogen Bond interaction with GLU12 (3.18 Å) and one Pi-Anion interaction with Asp145 (4.00 Å).All synthesized derivatives (6a-y and 7a-r) will be confirmed by the TLC, IR, NMR and MASS spectroscopy. Molecular docking studies give idea regarding the interaction of synthesized compound with protein of interest. The series of 6a-y and 7a-r will be synthesized, confirmed and tested for the in-vitro anticancer activity using human cancer cell line using MTT assay.
10 31 2023 10 31 2023 4825 4830 10.52711/0974-360X.2023.00782 https://rjptonline.org/AbstractView.aspx?PID=2023-16-10-52 Sidram AN, Sachin GL, Kalyane NV. Design, Synthesis and Study of Pharmacological and Biological Evaluation of some novel 1-2-4 Triazolo containing Thiosemicarbazide Derivatives. Research Journal of Pharmacy and Technology. 2011;4(9):1400-03. 10.5958/0974-360x.2017.00248.7 Pankaj K, Abhishek K, Jean SP et al. Synthesis and Biological Evaluation of Pyrimidine Derivatives via PyrrolylChalcones. Research Journal of Pharmacy and Technology. 2017;10(5):1392-94.doi: 10.5958/0974-360X.2017.00248.7 10.5958/0974-360x.2019.00031.3 Suman K, Vinita G, Sanchita S et al. Synthesis, Characterization and Antimicrobial Activities of Some New Amino-Pyrimidine Derivatives. Research J Pharm and Tech. 2019;12(1):167-71.doi: 10.5958/0974-360X.2019.00031.3 10.5958/2231-5691.2018.00002.3 Debarshi KM, Ruchi SS, Pranesh K. Murrayanine-Chalcone Transformed into Novel Pyrimidine Compounds Demonstrated promising Anti-Inflammatory Activity. Asian Journal of Pharmaceutical Research 2018; 8(1):6-10.DOI: 10.5958/2231-5691.2018.00002.3 10.52711/0974-360x.2021.00445 Kalpana D, RekhaS, Murugan et al. Synthesis, Characterization and Evaluation of some newer Pyrimidine derivatives as Anti-inflammatory Agents.Research Journal of Pharmacy and Technology. 2021 May 1;14(5):2519-34.doi: 10.52711/0974-360X.2021.00445 10.52711/0974-360x.2022.00403 Khedkar SA,Patil JS,Sabale PM. Design and Synthesis, In Silico Analysis of Condensed Pyrimidine derivatives as Potent Antimicrobial Agents. Research Journal of Pharmacy and Technology. 2022;15(6):2422-26.doi: 10.52711/0974-360X.2022.00403 10.5958/0974-360x.2020.01088.4 Shakila B,Krishnamoorthy, Senthamarai et al. Synthesis, Spectral Characterization and Anticancer activity of Novel Pyrimidine Derivatives. Research Journal of Pharmacy and Technology. 2020;13(12):6243-47.doi: 10.5958/0974-360X.2020.01088.4 10.52711/0974-360x.2021.00667 Vivek BP,Santosh RB, Parag GI.Synthesis, characterization and molecular docking studies on some new N-substituted 2-phenylpyrido[2,3-d]pyrimidine derivatives. Research Journal of Pharmacy and Technology. 2021;14(7):3846-54.doi: 10.52711/0974-360X.2021.00667 10.52711/0974-360x.2021.01078 Almakaiev MS, Dvinskikh NV,Almakaieva LG. Development of a combined solution of pyrimidine nucleotides with vitamin B6. Research Journal of Pharmacy and Technology. 2021;14(12):5384-87.DOI: 10.52711/0974-360X.2021.01078 10.52711/0974-360x.2021.01037 Prerana AC, Shailaja BJ. Docking Studies, Synthesis and Evaluation of Novel Pyrimidin-2-one Derivatives as a Dipeptidyl Peptidase IV Inhibitors. Research Journal of Pharmacy and Technology. 2021;14(11):5973-77.doi: 10.52711/0974-360X.2021.01037 10.52711/0974-360x.2021.01047 Nadia SM, Nada AS, Radhiyah AB. Preparation,Characterization and Study of Biological Activity for some new derivatives Mannich's bases derived from Shiff's bases. Research Journal of Pharmacy and Technology. 2021;14(11):6025-32.doi: 10.52711/0974-360X.2021.01047 10.52711/0974-360x.2021.00945 Khedkar SA,Patil JS,Sabale PM. Virtual Analysis of Condensed Pyrimidine Derivatives as COX II Inhibitors Potential Anti-inflammatory Agents. Research Journal of Pharmacy and Technology 2021;14(10):5423-26.doi: 10.52711/0974-360X.2021.00945 10.52711/0974-360x.2021.00889 Mandeep S, Prasad DN, Supriya A. Synthesis, Characterization and Biological Evaluation of Novel Triazolyl - Acridine Derivatives as Cytotoxic Agents. Research Journal of Pharmacy and Technology. 2021;14(10):5101-07.DOI: 10.52711/0974-360X.2021.00889 10.52711/0974-360x.2021.00842 Kavitha K, Srinivasan N, Mohan S et al. Insilco Design and Potential Cytotoxic agents EGFR Inhibitors of 4(3H) Quinazolinone Derivatives. Research Journal of Pharmacy and Technology. 2021;14(9):4849-55.doi: 10.52711/0974-360X.2021.00842

Item Type: Article
Subjects: Pharmaceutical Chemistry and Analysis > Pharmaceutics
Divisions: Pharmaceutical Chemistry and Analysis
Depositing User: Mr IR Admin
Date Deposited: 13 Sep 2024 10:55
Last Modified: 13 Sep 2024 10:55
URI: https://ir.vistas.ac.in/id/eprint/5939

Actions (login required)

View Item
View Item